Historical record - last NADAC effective date: 12/10/2014
Product Information
TIAZAC ER 180 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $1.5060 per EA under NDC 00187261330. Its NADAC has been published 41 times since Dec 10, 2014.
FDA first approved this application on Sep 11, 1995. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the diltiazem hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
Bausch Health US LLCNDC
00187261330
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
12/10/2014
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020401FDA Approved
9/11/1995
TE Code
AB4
On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for TIAZAC ER 180 MG CAPSULE has been published 41 times since Dec 10, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5060 per EA |
|---|---|
| All-time high | $1.5060 (Sep 16, 2015) |
| All-time low | $1.5060 (Dec 10, 2014) |
| Median price | $1.5060 |
| Average price | $1.5060 |
| Largest weekly change | 0.0% (Dec 17, 2014) |
| Weeks tracked | 41 |
| Tracking since | Dec 10, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 16, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIAZAC ER 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIAZAC ER 180 MG CAPSULE, manufactured by Bausch Health US LLC, is $1.5060 per EA (NDC 00187261330), effective Sep 16, 2015.
How has the price of TIAZAC ER 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIAZAC ER 180 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 41 weekly CMS publications since Dec 10, 2014.
What are the highest and lowest recorded NADAC prices for TIAZAC ER 180 MG CAPSULE?
Since Dec 10, 2014, the NADAC for TIAZAC ER 180 MG CAPSULE has ranged from a low of $1.5060 (Dec 10, 2014) to a high of $1.5060 (Sep 16, 2015), with a median of $1.5060 per EA.
Are there cheaper alternatives to TIAZAC ER 180 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIADYLT ER 180 MG CAPSULE, is $0.1559 per EA — about 90% below TIAZAC ER 180 MG CAPSULE.
Who manufactures TIAZAC ER 180 MG CAPSULE?
TIAZAC ER 180 MG CAPSULE (NDC 00187261330) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.